The success of copyright’s blockbuster initially sparked a boom for the drug industry, however recent changes present a complicated outlook for those considering a stake. Lower-cost alternatives are eating into profits, and continued litigation add further complexity to the situation. While certain companies could still gain from adjacent produc… Read More